BioForm Medical, Inc. is a privately-held, venture-backed, medical device company developing and commercializing injectable implant products for soft tissue augmentation (Radiesse(R) and Coaptite(R)) and topical preparations for dermatological conditions (Cutanix(R)). The company was incorporated in 1999 and acquired from Bristol-Myers Squibb certain proprietary technology and related assets, including the R&D and manufacturing facility currently housing many of our employees near Milwaukee, WI. BioForm Medical’s patented CaHA (Calcium Hydroxylapatite) technology platform has driven the development of a variety of injectable fillers that are made of small spherical particles of synthetic CaHA suspended in an aqueous gel carrier. BioForm Medical's CaHA technology has been in development for many years, starting in the early 1990's with functional studies, stability studies, biocompatibility studies, preclinical studies and toxicology assessments performed on BioForm Medical products.

Company was acquired by Merz Pharma